Follow the people · Insider
Peter Kuan-How Lin
Peter Kuan-How Lin files insider transactions with the SEC as a chief financial officer of Apollomics (APLM). We hold 1 disclosed purchase or sale filed since 17 April 2026, 1 of them in the last 90 days.
- Files forAPLM
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure17 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 31 March 2026 — 14 August 2026Chief Financial Officer · Apollomics (APLM)5 Form 4 lines · source: SEC Form 4
Everything they disclosed
5 entries, newest first — one per disclosure report, one per Form 4 line- ▲ bought on the open market 26,667 shares of ApollomicsSEC Form 417 August 2026CLASS A ORDINARY SHARES · traded 14 August 2026 · filed 17 August 2026
- exercised options over 10,000 shares of ApollomicsSEC Form 417 June 2026CLASS A ORDINARY SHARES · traded 15 June 2026 · filed 17 June 2026
- had shares withheld for tax on 3,588 shares of ApollomicsSEC Form 417 June 2026CLASS A ORDINARY SHARES · traded 15 June 2026 · filed 17 June 2026
- exercised options over 10,000 shares of Apollomics (a derivative holding)SEC Form 417 June 2026Restricted Stock Units · traded 15 June 2026 · filed 17 June 2026
- had shares withheld for tax on 3,582 shares of ApollomicsSEC Form 417 April 2026CLASS A ORDINARY SHARES · traded 31 March 2026 · filed 17 April 2026
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.